“Global Portable Ultrasound Bladder Scanner Market to reach a market value of USD 344.9 Million by 2031 growing at a CAGR of 3.8%”
The Global Portable Ultrasound Bladder Scanner Market size is expected to reach $344.9 million by 2031, rising at a market growth of 3.8% CAGR during the forecast period.
The Asia Pacific region has a high prevalence of urological disorders driven by lifestyle changes, environmental factors, and aging populations. Portable ultrasound bladder scanners play a crucial role in diagnosing and managing these urological conditions, contributing to their rising demand in the region. Consequently, the Asia Pacific region would acquire nearly, 30% of the total market share by 2031.
The expansion of healthcare infrastructure leads to the establishment of new hospitals, clinics, diagnostic centers, and other healthcare facilities. Furthermore, expanded healthcare infrastructure improves access to healthcare services, especially in underserved or remote areas. Therefore, the expansion of healthcare Infrastructure is driving the market's growth. Additionally, Minimally invasive procedures are preferred because they reduce patient discomfort and trauma compared to traditional invasive methods. Moreover, patients undergoing minimally invasive procedures typically experience faster recovery and shorter hospital stays. Thus, the growing preference for minimally invasive procedures propels the market's growth.
However, Limited reimbursement or low reimbursement rates for ultrasound bladder scanning procedures create a financial barrier for healthcare providers. Furthermore, limited reimbursement for ultrasound bladder scanning procedures can affect patient access to this diagnostic modality. Hence, limited reimbursement policies are hampering the growth of the market.
On the basis of end-use, the market is segmented into hospitals, diagnostic imaging centers, and others. In 2023, the diagnostic imaging centers segment attained 30.4% revenue share in the market. Diagnostic imaging centers are using Point-of-care testing solutions more frequently to improve patient care and workflow efficiency.
Based on product, the market is divided into 2D and 3D. The 3D segment acquired a 40.3% revenue share in the market in 2023. The three-dimensional imaging provided by 3D ultrasound bladder scanners offers improved diagnostic accuracy by providing detailed and comprehensive bladder images. Healthcare providers can better visualize abnormalities, such as bladder tumors or polyps, and accurately assess bladder volume and post-void residual urine, leading to more accurate diagnoses and treatment planning.
Free Valuable Insights: Global Portable Ultrasound Bladder Scanner Market size to reach USD 344.9 Million by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed a 36% revenue share in the market in 2023. North America has an extensive network of ambulatory care centers, hospitals, clinics, and diagnostic imaging centers, making it home to a highly developed healthcare infrastructure.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 258.5 Million |
| Market size forecast in 2031 | USD 344.9 Million |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 3.8% from 2024 to 2031 |
| Number of Pages | 163 |
| Number of Tables | 249 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, End-use, Region |
| Country scope |
|
| Companies Included | GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Verathon Inc. (Roper Technologies, Inc.), Infinium Medical, Inc., Advin Health Care, Caresono Technology Co.,Ltd., Becton, Dickinson and Company, ECHO-SON S.A. and Vitacon AS |
By Product
By End-use
By Geography
The Market size is projected to reach USD 344.9 million by 2031.
Expansion of healthcare infrastructure are driving the Market in coming years, however, Limited reimbursement policies restraints the growth of the Market.
GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Verathon Inc. (Roper Technologies, Inc.), Infinium Medical, Inc., Advin Health Care, Caresono Technology Co.,Ltd., Becton, Dickinson and Company, ECHO-SON S.A. and Vitacon AS.
The expected CAGR of this Market is 3.8% from 2023 to 2031.
The 2D segment led the market by Product in 2023; thereby, achieving a market value of $199.5 million by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $119,083.4 million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 